PS1087 ESHAP VERSUS GEMOX IN MANAGEMENT OF RELAPSED OR REFRACTORY LYMPHOMA: A PROSPECTIVE RANDOMIZED STUDY

Authors
Publication date
1 June 2019
Publisher
Ovid Technologies (Wolters Kluwer Health)
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1097%2F01.hs9.0000...
      Last time updated on 11/03/2025